Navigation Links
Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting
Date:4/30/2009

CALGARY, April 30 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2009 Annual and Special Meeting of the Shareholders will be held on Tuesday, May 5, 2009 at 2:30 p.m. (MT) at the Telus World of Science, 701-11 Street SW, Calgary.

Following the business portion of the meeting, Dr. Brad Thompson, President and CEO of Oncolytics, will discuss recent progress in developing REOLYSIN(R) as a potential cancer therapeutic.

A live audio webcast of the presentation will begin at approximately 2:45 p.m. (MT) at:

http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2632960 or on the company's website at www.oncolyticsbiotech.com. It is recommended that listeners log on 15 minutes in advance of the presentation to register and download any necessary software.

An audio replay will be accessible following the presentation at www.oncolyticsbiotech.com.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN, its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit www.oncolyticsbiotech.com

The presentation time is subject to change. This release and the presentation related thereto contain forward-looking statements which involve known and unknown risks, delays, u
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioFinance 2009
2. Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial
3. Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial
4. Oncolytics Biotech(R) Inc. Collaborators Present Reovirus Research at Replicating Oncolytic Virus Meeting
5. Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial
6. Oncolytics Biotech(R) Inc. Collaborators Update Combination REOLYSIN(R) and Docetaxel Trial Results at Replicating Oncolytic Virus Meeting
7. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting
8. Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
9. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America
10. Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent
11. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...rd Gephardt Brings Together A-List from New Jersey...st and Brightest Forum on Medical Innovation" ,...re/ -- Several of New Jersey,s most prominent lead...technology gathered today at the Liberty Science C...ion in New Jersey, and throughout the United State...
(Date:12/1/2009)...ire/ -- Expanding its European reach for bacterial... appointed Lake Chemicals and Minerals of England ...ingham, England. ,, Osprey breeds trillions of... waste water, and environmental markets. Its bacte..., and clean up industrial and marine spills. In ag...
(Date:12/1/2009).../ -- The Burrill Biotech Select Index managed to c... The Select,s gain of 4.5 percent mirrored what wa...with the Dow up 6.5 percent and the NASDAQ up 4.8 ... two trading days of the month despite investor wo... and Dubai,s reported debt woes. ,, Almost all ...
(Date:12/1/2009)...announced a collaborative research agreement with ...ting EpiVax’s proprietary Tregitope technolo...une responses to certain drugs. In the course of t...e technology will be evaluated for its effect on t... (Vocus) December 2, 2009 -- ...
Breaking Biology Technology:New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3
...EXTON, Pa., Oct. 27 BioTrends Research Group, Inc...g, privately-held businesses in,the Philadelphia r...of the,Wharton Small Business Development Center, ...and the Philadelphia Business Journal. The ranking...recognition is a testament to the uniqueness of ou...
...- Conference call today at 4:30 p.m. ET -, SOUTH ...es, Inc. (Nasdaq: MGRM ) today reported financial..., The Company had revenues of $16.1 million for t...llion in the third quarter of 2007. This,growth wa... HIV patients to,be treated with Selzentry(TM), Pf...
...Record results mark 21st consecutive quarter of re...lights: - Product revenues increased 29% to ...Business revenues increased by 48% - Shipped ... IRVINE, Calif., Oct. 27 Masimo Corporation,(Nas...d Measure-Through,Motion and Low Perfusion pulse o...
Other Biology Technology:Monogram Announces 2008 Third Quarter Financial Results 2Monogram Announces 2008 Third Quarter Financial Results 3Monogram Announces 2008 Third Quarter Financial Results 4Monogram Announces 2008 Third Quarter Financial Results 5Monogram Announces 2008 Third Quarter Financial Results 6Monogram Announces 2008 Third Quarter Financial Results 7Monogram Announces 2008 Third Quarter Financial Results 8Monogram Announces 2008 Third Quarter Financial Results 9Monogram Announces 2008 Third Quarter Financial Results 10Monogram Announces 2008 Third Quarter Financial Results 11Monogram Announces 2008 Third Quarter Financial Results 12Monogram Announces 2008 Third Quarter Financial Results 13Monogram Announces 2008 Third Quarter Financial Results 14Monogram Announces 2008 Third Quarter Financial Results 15Masimo Reports Third Quarter 2008 Financial Results 2Masimo Reports Third Quarter 2008 Financial Results 3Masimo Reports Third Quarter 2008 Financial Results 4Masimo Reports Third Quarter 2008 Financial Results 5Masimo Reports Third Quarter 2008 Financial Results 6Masimo Reports Third Quarter 2008 Financial Results 7Masimo Reports Third Quarter 2008 Financial Results 8Masimo Reports Third Quarter 2008 Financial Results 9Masimo Reports Third Quarter 2008 Financial Results 10Masimo Reports Third Quarter 2008 Financial Results 11Masimo Reports Third Quarter 2008 Financial Results 12Masimo Reports Third Quarter 2008 Financial Results 13
(Date:11/30/2009)...Two so-called invasion proteins are crucial for in...face of human cells, which stimulates the host cel...r molecules exert a different function, for exampl... The group,s results have now been published in th...ogy ". , Spoiled meat is one of the sources for ...
(Date:11/30/2009)...A new research report published in the December 20...y give men similar type of control over their fert...because scientists have found how and where androg... sperm production and male fertility. This opens a..." for men. The discovery also offers hope to those...
(Date:11/26/2009)...Ecologists have at last worked out a way of using ...ize of bird populations. This is the first time so...ranslated into accurate estimates of bird species,...in the British Ecological Society,s Journal of Ap... could lead to a major advance in our ability to m...
Breaking Biology News(10 mins):It takes 2 to infect 2Ecologists sound out new solution for monitoring cryptic species 2Vivakor Presents at Nutraceutical Event 61275 1Vivakor Presents at Nutraceutical Event 61275 2Vivakor Presents at Nutraceutical Event 61275 3Vivakor Presents at Nutraceutical Event 61275 4Vivakor Presents at Nutraceutical Event 61275 5Vivakor Presents at Nutraceutical Event 61275 6Pregis Announces Third Quarter 2009 Financial Results 61271 1Pregis Announces Third Quarter 2009 Financial Results 61271 2Pregis Announces Third Quarter 2009 Financial Results 61271 3Pregis Announces Third Quarter 2009 Financial Results 61271 4Pregis Announces Third Quarter 2009 Financial Results 61271 5Pregis Announces Third Quarter 2009 Financial Results 61271 6Pregis Announces Third Quarter 2009 Financial Results 61271 7Pregis Announces Third Quarter 2009 Financial Results 61271 8Pregis Announces Third Quarter 2009 Financial Results 61271 9Pregis Announces Third Quarter 2009 Financial Results 61271 10Pregis Announces Third Quarter 2009 Financial Results 61271 11Pregis Announces Third Quarter 2009 Financial Results 61271 12Pregis Announces Third Quarter 2009 Financial Results 61271 13Pregis Announces Third Quarter 2009 Financial Results 61271 14Pregis Announces Third Quarter 2009 Financial Results 61271 15Pregis Announces Third Quarter 2009 Financial Results 61271 16AvidBiotics Corp Granted Key U S and European Patents on Unique Protein Modification Platform 14820 1AvidBiotics Corp Granted Key U S and European Patents on Unique Protein Modification Platform 14820 2
...robiology (ASM) has been honored with non-profit p... public outreach initiatives. The awards were ann...The Society,s MicrobeWorld Video series received t..., the online video series strives to increase publ...e microbes play on our planet. Since then the ser...
... uncanny ability to view the activity of any chose...amera. , With GeneVision, military commanders cou...ted troops. Retailers could track genes related to...helor" would enjoy yet one more secret advantage o.... Ethically suspect? Certainly. Preposterous? Not ...
...in The FASEB Journal shows that the equivalent o...ngested during pregnancy may be enough to affect f...ion over the entire lifespan of the child. In addi...ely minimal amount of exposure may lead to higher ...ere not exposed to caffeine. Although the study wa...
Other Biology News:Real-time gene monitoring developed 2A low dose of caffeine when pregnant may damage the heart of offspring for a lifetime 2
...s a dedicated imaging system for detection of very... Equipped with an extreme sensitive camera to dete...esearch, infectious disease research, gene express...s the only imager with a motor-driven camera insid...
...s a dedicated imaging system for fluorescent light...sitive camera to detect low level light in animals...esearch, gene expression, circadian rhythm, gels a... a motor-driven camera inside the light-tight cabi...
Mouse Anti-Human COG2 Monoclonal Antibody, Unconjugated, Clone 4C8 from Abnova Corporation
Mouse Anti-Human AGTRAP Polyclonal Antibody, Unconjugated from Abnova Corporation
Biology Products: